Shares of Hemispherx (HEB) Spike Mid-Day Ahead of Ampligen Approval/Rejection
Tweet Send to a Friend
Shares of Hemispherx Biopharma (AMEX: HEB) have jumped mid-day despite no news coming out ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
